Conflict of interest: Dr. Richard Stone has been a consultant for Novartis.
Clinical outcome of patients with acute promyelocytic leukemia and FLT3 mutations†
Article first published online: 27 OCT 2010
Copyright © 2010 Wiley-Liss, Inc.
American Journal of Hematology
Volume 85, Issue 12, pages 956–957, December 2010
How to Cite
Singh, H., Werner, L., DeAngelo, D., Ballen, K., Amrein, P., Wadleigh, M., Neuberg, D., Fox, E., Stone, R. and Attar, E. (2010), Clinical outcome of patients with acute promyelocytic leukemia and FLT3 mutations. Am. J. Hematol., 85: 956–957. doi: 10.1002/ajh.21867
- Issue published online: 23 NOV 2010
- Article first published online: 27 OCT 2010
- Accepted manuscript online: 7 SEP 2010 12:00AM EST
- Leukemia Discovery and Treatment Fund
- Massachusetts General Hospital